US2012135940A1PendingUtilityA1
Pharmaceutical compositions for lipophilic drugs
Individually held — no corporate assignee on recordPriority: Jan 22, 1996Filed: Jan 12, 2012Published: May 31, 2012
Est. expiryJan 22, 2016(expired)· nominal 20-yr term from priority
A61K 9/4858A61K 9/107A61K 9/1075A61K 38/13
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in a polar lipid, such as having a C 6 -C 12 fatty acid monoglyceride content of at least about 50%, surfactants and triglycerides. The composition forms a fine emulsion on exposure to water. The encapsulated dosage form of this composition needs neither a hydrophilic component nor air-tight blister packaging, and is particularly suitable for oral administration.
Claims
exact text as granted — not AI-modified1 - 19 . (canceled)
20 . A composition for oral administration comprising:
a cyclosporin and a carrier medium; wherein the carrier medium is selected to cause the composition, on contact with an aqueous phase, to spontaneously form a clear, fine emulsion of mean particle size of less than about 50 nm, wherein the composition does not contain a hydrophilic phase, and wherein the composition comprises a polyoxyethylated natural vegetable oil, a polyoxyethylated hydrogenated vegetable oil, or a mixture thereof.
21 . The composition of claim 20 , wherein the composition comprises PEG castor oil.
22 . The composition of claim 20 , further comprising a monoglyceride, a diglyceride, a medium-chain triglyceride, or a combination thereof.
23 . The composition of claim 20 , further comprising a monoglyceride, a diglyceride, or a combination thereof.
24 . The composition of claim 20 , wherein the composition comprises polysorbate 80.
25 . The composition of claim 20 , wherein the composition comprises polysorbate 20.
26 . The composition of claim 20 , wherein the composition comprises polyglycolyzed glycerides.
27 . A composition for oral administration comprising:
a cyclosporin and a carrier medium comprising a combination of two or more surfactants; wherein the combination of surfactants are selected to cause the composition, on contact with an aqueous phase, to spontaneously form a clear, fine emulsion, and wherein the composition does not contain a hydrophilic phase, and wherein the composition comprises a polyoxyethylated natural vegetable oil, a polyoxyethylated hydrogenated vegetable oil, or a mixture thereof.Join the waitlist — get patent alerts
Track US2012135940A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.